Articles

P.23 An aggressive, acute onset intravascular large B-cell lymphoma presenting with marked peripheral erythroblastosis: a case report

BJH - volume 11, issue Abstract Book BHS, february 2020

M. Mylemans , E. Vermeulen , H. Maes , M. Criel , I. Geerts MD

Read more

P.43 Alectinib-associated low grade hemolysis: unknown adverse reaction

BJH - volume 11, issue Abstract Book BHS, february 2020

N. Makki , I. Geerts MD, E. Vermeulen , J. Moerman MD, A. Van Den Bergh , M. Criel

Read more

Cyclic thrombocytopenia in a patient with polycythaemia vera: a case report

BJH - volume 9, issue 5, september 2018

I. Depoortere MD, V. Maertens MD, M. Criel , M. Vanden Driessche MD, I. Geerts MD

SUMMARY

We present a case of a 73-year old patient with polycythaemia vera in whom cyclic thrombocytopenia was diagnosed. Strong fluctuations in platelet count, ranging from 31 to 1334 × 103/µL, were noticed after onset of hydroxyurea therapy. We did a literature search to find possible underlying causes of cyclic thrombocytopenia that could guide us towards a fast and appropriate diagnosis and an optimal treatment. In literature, provoked and unprovoked oscillations in platelet numbers have been described. Unprovoked oscillations can most likely be attributed to an unstable haematopoietic stem cell pool, as can be seen in polycythaemia vera. Provoked oscillations could be associated with myelosuppressive agents such as hydroxyurea. In both situations, a decrease in platelet count can be followed by a compensatory thrombopoietin-induced stimulation of megakaryocytes. Frequent hydroxyurea dose adjustments may be carried out in an attempt to control this cyclic pattern but, by contrast, may provoke a bouncing ball effect on platelet count. Certain patients will therefore benefit from maintaining therapy at a constant dose; while certain others require withholding or switching therapy. Cyclic thrombocytopenia is a rare finding and is frequently misdiagnosed as immune thrombocytopenia. If hydroxyurea-treated patients with a chronic myeloproliferative disorder present with thrombocytopenia, cyclic thrombocytopenia should be considered. Intensive follow-up with regular control of platelet count and personalised therapy is mandatory.

(BELG J HEMATOL 2018;9(5):188–91)

Read more

P14 Cyclic thrombocytopenia in a patient with polycythemia vera: a case report

BJH - 2018, issue Abstract Book BHS, february 2018

I. Depoortere MD, V. Maertens MD, M. Criel , I. Geerts MD

Read more

A-140 STAPHYLOCOCCUS AUREUS AND STAPHYLOCOCCUS LUGDUNENSIS BIND VON WILLEBRAND FACTOR TO OVERCOME SHEAR STRESS AND CAUSE ENDOCARDITIS

BJH - volume 8, issue Abstract Book BSTH, february 2017

L. Liesenborghs , J. Claes , M. Peetermans , M. Lox , R. Veloso , M. Criel , S. van Kerckhoven , K. Cludts , prof. dr. W. Peetermans MD, PhD, T. Vanassche MD, PhD, M. Hoylaerts , P. Verhamme MD, PhD

Read more

A-112 ABSENCE OF PEAR1 DOES NOT AFFECT MURINE PLATELET FUNCTION

BJH - volume 8, issue Abstract Book BSTH, february 2017

M. Criel , B. Izzi , C. Vandenbriele MD, PhD, L. Liesenborghs , S. van Kerckhoven , M. Lox , K. Cludts , E. A.V. Jones , T. Vanassche MD, PhD, P. Verhamme MD, PhD, M. Hoylaerts

Read more

PP4.1 Mutation frequency of SETBP1, ASXL1 and CSF3R in myeloid malignancies: retrospective analysis of 123 patients

BJH - volume 7, issue Abstract Book BHS, january 2016

M. Criel , S. Vermeire , B. Cauwelier MD, PhD, F. Nollet PhD, MSc

Read more
X